Latest Insider Transactions at Ptc Therapeutics, Inc. (PTCT)
This section provides a real-time view of insider transactions for Ptc Therapeutics, Inc. (PTCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PTC THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PTC THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,657
-13.86%
|
$175,362
$66.0 P/Share
|
|
Feb 08
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,657
+12.18%
|
$87,681
$33.02 P/Share
|
|
Feb 02
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
652
-3.8%
|
$37,164
$57.64 P/Share
|
|
Feb 01
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
368
-2.1%
|
$20,608
$56.96 P/Share
|
|
Feb 01
2021
|
Dawn Svoronos |
SELL
Open market or private sale
|
Direct |
506
-1.81%
|
$28,336
$56.96 P/Share
|
|
Feb 01
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
283
-1.84%
|
$15,848
$56.96 P/Share
|
|
Feb 01
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,968
-2.39%
|
$110,208
$56.96 P/Share
|
|
Feb 01
2021
|
Eric Pauwels CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
362
-0.98%
|
$20,272
$56.96 P/Share
|
|
Feb 01
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
28
-1.52%
|
$1,568
$56.96 P/Share
|
|
Feb 01
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
973
-2.65%
|
$54,488
$56.96 P/Share
|
|
Feb 01
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
778
-1.58%
|
$43,568
$56.96 P/Share
|
|
Feb 01
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
541
-2.27%
|
$30,296
$56.96 P/Share
|
|
Jan 25
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
350
-2.23%
|
$21,700
$62.05 P/Share
|
|
Jan 25
2021
|
Eric Pauwels CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
431
-1.16%
|
$26,722
$62.05 P/Share
|
|
Jan 25
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
275
-1.14%
|
$17,050
$62.05 P/Share
|
|
Jan 25
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
541
-11.57%
|
$33,542
$62.65 P/Share
|
|
Jan 15
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,300
-18.21%
|
$296,700
$69.09 P/Share
|
|
Jan 15
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+15.41%
|
$163,400
$38.98 P/Share
|
|
Jan 13
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,947
-6.8%
|
$260,502
$66.57 P/Share
|
|
Jan 13
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,288
+7.61%
|
$46,032
$14.62 P/Share
|
|
Jan 08
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
26,033
-20.24%
|
$1,796,277
$69.75 P/Share
|
|
Jan 08
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,033
+16.36%
|
$598,759
$23.28 P/Share
|
|
Jan 08
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-11.67%
|
$379,500
$69.9 P/Share
|
|
Jan 08
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+18.15%
|
$209,000
$38.98 P/Share
|
|
Jan 08
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
1,300
-35.25%
|
$89,700
$69.0 P/Share
|
|
Jan 08
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,300
+26.06%
|
$35,100
$27.05 P/Share
|
|
Jan 07
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,886
-16.75%
|
$264,248
$68.98 P/Share
|
|
Jan 07
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,886
+14.35%
|
$147,668
$38.98 P/Share
|
|
Jan 06
2021
|
Michael Schmertzler |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+3.09%
|
-
|
|
Jan 06
2021
|
Glenn Jr Md Phd Steele |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+33.33%
|
-
|
|
Jan 06
2021
|
David P Southwell |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+33.33%
|
-
|
|
Jan 06
2021
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+38.71%
|
-
|
|
Jan 06
2021
|
Jerome B Zeldis |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+33.33%
|
-
|
|
Jan 06
2021
|
Allan Steven Jacobson |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+24.27%
|
-
|
|
Jan 06
2021
|
Dawn Svoronos |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+5.58%
|
-
|
|
Jan 06
2021
|
Emma Reeve |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+27.6%
|
-
|
|
Jan 06
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
600
+20.08%
|
-
|
|
Jan 06
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,200
+21.71%
|
-
|
|
Jan 06
2021
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+31.79%
|
-
|
|
Jan 06
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+32.36%
|
-
|
|
Jan 06
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
3,960
+20.13%
|
-
|
|
Jan 06
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
27,600
+25.12%
|
-
|
|
Jan 06
2021
|
Eric Pauwels CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,200
+21.48%
|
-
|
|
Jan 06
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Grant, award, or other acquisition
|
Direct |
10,200
+17.19%
|
-
|
|
Jan 06
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+30.93%
|
-
|
|
Jan 05
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
124
-3.3%
|
$7,688
$62.37 P/Share
|
|
Jan 05
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
502
-1.85%
|
$31,124
$62.37 P/Share
|
|
Jan 05
2021
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
316
-3.22%
|
$19,592
$62.37 P/Share
|
|
Jan 05
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
666
-2.72%
|
$41,292
$62.37 P/Share
|
|
Jan 05
2021
|
Stuart Walter Peltz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,402
-2.5%
|
$86,924
$62.37 P/Share
|